Recruiting Pulmonary Fibrosis Studies in Scottsdale
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
Adults 18 years of age and older or above legal age with lung fibrosis related to systemic autoimmune rheumatic disease can participate in this study. People can only take part if they show no improve...
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
The goal of this clinical trial is to learn about INS018\_055 in adults with Idiopathic Pulmonary Fibrosis (IPF). The primary objective is to evaluate the safety and tolerability of INS018\_055 orall...
About Pulmonary Fibrosis Clinical Trials in Scottsdale
Pulmonary fibrosis is a condition in which the lung tissue becomes damaged and scarred, making it difficult for the lungs to function properly. Idiopathic pulmonary fibrosis (IPF) is the most common form with unknown cause. Antifibrotic medications can slow progression, and lung transplant may be considered.
There are currently 2 pulmonary fibrosis clinical trials recruiting participants in Scottsdale, ARIZONA. These studies are seeking a combined 460 participants. Research is being sponsored by Boehringer Ingelheim, InSilico Medicine Hong Kong Limited. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Fibrosis Clinical Trials in Scottsdale — FAQ
Are there pulmonary fibrosis clinical trials in Scottsdale?
Yes, there are 2 pulmonary fibrosis clinical trials currently recruiting in Scottsdale, ARIZONA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Scottsdale?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Scottsdale research site will contact you about next steps.
Are clinical trials in Scottsdale free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Scottsdale studies also compensate for your time and travel.
What pulmonary fibrosis treatments are being tested?
The 2 active trials in Scottsdale are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary fibrosis.
Data updated March 2, 2026 from ClinicalTrials.gov